VYNE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.750 USD | -8.94% |
|
-31.25% | -17.91% |
EPS & Dividend: VYNE Therapeutics Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -141.8 | -25.56 | -7.28 | -2.78 | -0.96 | -1.13 | -1.16 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 113.760 | 18.360 | 2.700 | 2.330 | 2.750 | 2.750 | 2.750 |
| Nbr of stocks (in thousands) | 2,332 | 2,973 | 3,224 | 13,957 | 14,751 | 14,751 | - |
| Announcement Date | 3/4/21 | 3/17/22 | 3/9/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: VYNE Therapeutics Inc.
| 2025-02-26 | Q4 2024 Earnings Release (Projected) |
| 2025-05-07 | Q1 2025 Earnings Release (Projected) |
| 2025-08-07 | Q2 2025 Earnings Release (Projected) |
| 2025-11-05 | Q3 2025 Earnings Release (Projected) |
| Yield (Y) | Yield (Y) | P/E ratio (Y) | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -257.17x | 6.516 | 8.94x | ||
| -.--% | -.--% | 18.58x | 2.611 | 4.78x | ||
| -.--% | -.--% | 685.1x | 9.196 | 17.85x | ||
| -.--% | -.--% | -35.31x | 1.374 | 5.2x | ||
| +1.85% | +2.01% | 16.3x | 2.505 | 3.63x | ||
| -.--% | -.--% | -33.92x | 5.852 | 4.85x | ||
| -.--% | -.--% | 35.56x | 5.171 | 5.41x | ||
| -.--% | -.--% | 18.66x | 2.969 | 3.79x | ||
| - | - | -59.56x | - | - | ||
| Average | +0.23% | +0.25% | 43.14x | 4.52 | 6.81x | |
| Weighted average by Cap. | +0.12% | +0.13% | 0.06x | 4.95 | 7.75x |
